-
Published 1/1/2019
Surman C, Ceranoglu A, Vaudreuil C, Albright B, Uchida M, Yule A, Spencer A, Boland H, Grossman R, Rhodewalt L, Fitzgerald M, Biederman J. Does L-Methylfolate Supplement Methylphenidate Pharmacotherapy in Attention-Deficit/Hyperactivity Disorder?: Evidence of Lack of Benefit From a Double-Blind, Placebo-Controlled, Randomized Clinical Trial. J Clin Psychopharmacol. 2019 Jan/Feb; 39(1):28-38. PMID: 30566416.
-
Published 1/1/2019
Spencer AE, Chiang C, Plasencia N, Biederman J, Sun Y, Gebara C, Jellinek M, Murphy JM, Zima BT. Utilization of Child Psychiatry Consultation Embedded in Primary Care for an Urban, Latino Population. J Health Care Poor Underserved. 2019; 30(2):637-652. PMID: 31130542.
-
Published 7/13/2018
Spencer AE, Plasencia N, Sun Y, Lucke C, Haile H, Cronin R, Faraone SV, Jellinek M, Murphy JM, Biederman J. Screening for Attention-Deficit/Hyperactivity Disorder and Comorbidities in a Diverse, Urban Primary Care Setting. Clin Pediatr (Phila). 2018 10; 57(12):1442-1452. PMID: 30003797.
-
Published 3/1/2018
Spencer TJ, Bhide P, Zhu J, Faraone SV, Fitzgerald M, Yule AM, Uchida M, Spencer AE, Hall AM, Koster AJ, Feinberg L, Kassabian S, Storch B, Biederman J. The Mixed Opioid Receptor Antagonist Naltrexone Mitigates Stimulant-Induced Euphoria: A Double-Blind, Placebo-Controlled Trial of Naltrexone. J Clin Psychiatry. 2018 Mar/Apr; 79(2). PMID: 29617066.
-
Published 1/1/2018
Spencer TJ, Bhide P, Zhu J, Faraone SV, Fitzgerald M, Yule AM, Uchida M, Spencer AE, Hall AM, Koster AJ, Biederman J. Opiate Antagonists Do Not Interfere With the Clinical Benefits of Stimulants in ADHD: A Double-Blind, Placebo-Controlled Trial of the Mixed Opioid Receptor Antagonist Naltrexone. J Clin Psychiatry. 2018 Jan/Feb; 79(1). PMID: 28640990.